JFS Wealth Advisors’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
JFS Wealth Advisors's RNTX Position: Q3 2026 in Review
JFS Wealth Advisors held its Rein Therapeutics (RNTX) position steady in Q3 2026 at 1,590 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.
JFS Wealth Advisors first reported a position in RNTX in Q3 2021 and has held it in 21 quarters since. The position peaked at $32K in Q3 2021. 64 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.
- JFS Wealth Advisors held 1,590 shares of Rein Therapeutics worth $1.28K as of Q3 2026.
- JFS Wealth Advisors left its Rein Therapeutics share count unchanged in Q3 2026.
- Rein Therapeutics made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q3 2026, its #1724 holding.
- JFS Wealth Advisors first reported a position in Rein Therapeutics in Q3 2021 and has held it in 21 quarters since.
- JFS Wealth Advisors's Rein Therapeutics position peaked at $32K in Q3 2021.
- 64 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.
Based on JFS Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.